PharmaShots | Incisive News in 3 Shots

Subscribe Now

kashiv biosciences

Kashiv BioSciences Partners with Amneal Pharmaceuticals to Commercialize ADL018 (Biosimilar, Xolair)

Kashiv BioSciences Partners with Amneal Pharmaceuticals to Commercialize ADL018 (Biosimilar, Xolair)

July 2, 2024

Kashiv BioSciences Reports the First Patient Enrolment of ADL018 (biosimilar, omalizumab) in the P-III Clinical Study for Chronic Spontaneous Urticaria

Kashiv BioSciences Reports the First Patient Enrolment of ADL018 (biosimilar, omalizumab) in the P-III Clinical Study for Chronic...

October 3, 2023

Kashiv Biosciences Reports P-I Clinical Study Results of ADL018 (biosimilar, omalizumab)

Kashiv Biosciences Reports P-I Clinical Study Results of ADL018 (biosimilar, omalizumab)

July 5, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us